2024 Full Event Guide
Browse the Full Event Guide to Discover:
- Latest characterization methods for guides, nucleases, delivery vehicles, and full drug constructs
- Robust non-clinical and CMC assays, including potency assays, NGS, on-/off- target sequencing strategy, and HPLC and PCR analysis
- How to comprehensively meet regulatory expectations for analytical data to support IND submissions
![2nd CRISPR-Based Therapy Analytical Development - 2024 Event Guide 2nd CRISPR-Based Therapy Analytical Development - 2024 Event Guide](https://crispr-analytical-development.com/wp-content/uploads/sites/887/2024/07/2nd-CRISPR-Based-Therapy-Analytical-Development-2024-Event-Guide-scaled.jpg)
Having trouble downloading the brochure? Let us know and we’ll email it to you instead
![Zack Zhang Zak Zhang, Beam Therapeutics - CRISPR Based Therapy Analytical Development Summit](https://crispr-analytical-development.com/wp-content/uploads/sites/887/bb-plugin/cache/Zack-Zhang-1-circle-5fd75eae5b9b78bb634d6718b6d59468-pvbkiemqcno7.jpg)
“With a broad representation from industry, academia, and regulators, I look forward to attending this year’s CRISPR-Based Therapy Analytical Development Summit and exchange ideas with peer researchers and developers.”
- Zack Zhang, Director, Analytical Development at Takeda Pharmaceuticals